|
- Supplier contact information - AstraZeneca
Please note that details of the AstraZeneca address that should be used on supplier invoices can be found on the AZ PO document In line with our commitments to sustainability, AZ’s preferred method of invoice receipt is paperless Wherever possible, suppliers should submit invoices electronically – by the Coupa Supplier Portal or by Ariba - iBuy (in China) or by email Invoices sent in
- AstraZeneca Suppliers
E-Invoicing Our preferred method of invoice receipt is paperless Wherever possible, suppliers should submit invoices electronically – by the Coupa Supplier Portal (CSP) or the Supplier Actionable Notification (SAN)
- AstraZeneca Websites
Medicines Oncology BioPharmaceuticals Cardiovascular, Renal and Metabolism Respiratory Immunology Vaccines and Immune Therapies Rare Disease All medicines
- Contact Us - Our Company - AstraZeneca
For general enquiries, please call our corporate switchboard either in the UK or USA, using the phone numbers shown
- AstraZeneca - Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide
- Locations - AstraZeneca
Site map Cookie Policy Privacy policy Job Application Privacy Notice Legal notice Astrazeneca com
- Country Sites - AstraZeneca
View Our Country Sites Here - AstraZenecaYou are about to access AstraZeneca historic archive material Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data Please refer to your approved national product label (SmPC) for
- Partnering - AstraZeneca
Partnering with AstraZenecaExternally sponsored scientific research can expand knowledge related to a product or associated disease areas It may help to advance science and contribute to the development of better medicines Through this platform, we offer access to compounds for clinical research across all phases of drug development, as well as for non-clinical research in the non-oncology
|
|
|